المؤلفون: Liu, Ming, Gu, Weijun, Chen, Li, Li, Yanbing, Kuang, Hongyu, Du, Jianling, Alvarez, Agustina, Lauand, Felipe, Souhami, Elisabeth, Zhang, Jiewen, Xu, Weiya, Du, Qin, Mu, Yiming

المساهمون: Sanofi

المصدر: Diabetes, Obesity and Metabolism ; ISSN 1462-8902 1463-1326

الإتاحة: https://doi.org/10.1111/dom.15724Test

المؤلفون: Guo, Xiaohui, Yang, Wenying, Zhang, Junqing, Dong, Xiaolin, Liu, Ming, Gu, Shenghong, Lauand, Felipe, Li, Lingyu, Huang, Qiong, Kang, Lei, Souhami, Elisabeth

المصدر: Diabetes, Obesity and Metabolism ; volume 25, issue 7, page 2005-2011 ; ISSN 1462-8902 1463-1326

الإتاحة: https://doi.org/10.1111/dom.15074Test

المؤلفون: Yang, Wenying, Dong, Xiaolin, Li, Qingju, Cheng, Zhifeng, Yuan, Guoyue, Liu, Ming, Xiao, Jianzhong, Gu, Shenghong, Niemoeller, Elisabeth, Chen, Lijuan, Ping, Lin, Souhami, Elisabeth

المساهمون: Sanofi

المصدر: Diabetes, Obesity and Metabolism ; volume 24, issue 8, page 1522-1533 ; ISSN 1462-8902 1463-1326

الإتاحة: https://doi.org/10.1111/dom.14722Test

المؤلفون: McCrimmon, Rory J., Home, Philip, Cheng, Alice Y. Y., Giorgino, Francesco, Fonseca, Vivian, Souhami, Elisabeth, Alvarez, Agustina, Picard, Pascaline, Rosenstock, Julio

المصدر: McCrimmon , R J , Home , P , Cheng , A Y Y , Giorgino , F , Fonseca , V , Souhami , E , Alvarez , A , Picard , P & Rosenstock , J 2022 , ' Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin : An analysis of the SoliMix trial ' , Diabetes, Obesity and Metabolism , vol. 24 , no. 12 , pp. 2391-2399 . https://doi.org/10.1111/dom.14825Test

مصطلحات موضوعية: BIAsp 30, fixed-ratio combination, hypoglycaemia, iGlarLixi, SoliMix, type 2 diabetes, /dk/atira/pure/subjectarea/asjc/1300/1310, name=Endocrinology, /dk/atira/pure/subjectarea/asjc/2700/2724, name=Internal Medicine, /dk/atira/pure/subjectarea/asjc/2700/2712, Diabetes and Metabolism

وصف الملف: application/pdf

العلاقة: https://discovery.dundee.ac.uk/en/publications/a0ea901b-6e77-4cb8-8fac-f04bbd27eadeTest

الإتاحة: https://doi.org/10.1111/dom.14825Test
https://discovery.dundee.ac.uk/en/publications/a0ea901b-6e77-4cb8-8fac-f04bbd27eadeTest
https://discovery.dundee.ac.uk/ws/files/79140808/Diabetes_Obesity_Metabolism_2022_McCrimmon_Hypoglycaemia_events_with_iGlarLixi_versus_premix_biphasic_insulin_aspart.pdfTest
http://www.scopus.com/inward/record.url?scp=85136896992&partnerID=8YFLogxKTest

المؤلفون: Yuan, Xiaoyong, Guo, Xiaohui, Zhang, Junqing, Dong, Xiaolin, Lu, Yibing, Pang, Wuyan, Gu, Shenghong, Niemoeller, Elisabeth, Ping, Lin, Nian, Gaowei, Souhami, Elisabeth

المساهمون: Sanofi

المصدر: Diabetes, Obesity and Metabolism ; volume 24, issue 11, page 2182-2191 ; ISSN 1462-8902 1463-1326

الإتاحة: https://doi.org/10.1111/dom.14803Test

المؤلفون: McCrimmon, Rory J., Lamotte, Mark, Ramos, Mafalda, Alsaleh, Abdul Jabbar Omar, Souhami, Elisabeth, Lew, Elisheva

المصدر: McCrimmon , R J , Lamotte , M , Ramos , M , Alsaleh , A J O , Souhami , E & Lew , E 2021 , ' Cost-Effectiveness of iGlarLixi Versus iDegLira in Type 2 Diabetes Mellitus Inadequately Controlled by GLP-1 Receptor Agonists and Oral Antihyperglycemic Therapy ' , Diabetes Therapy , vol. 12 , no. 12 , pp. 3231-3241 . https://doi.org/10.1007/s13300-021-01156-1Test

مصطلحات موضوعية: Cost-effectiveness, Cost-utility, GLP-1 receptor agonist, iGlarLixi, Type 2 diabetes mellitus, United Kingdom, /dk/atira/pure/subjectarea/asjc/2700/2724, name=Internal Medicine, /dk/atira/pure/subjectarea/asjc/2700/2712, name=Endocrinology, Diabetes and Metabolism

وصف الملف: application/pdf

العلاقة: https://discovery.dundee.ac.uk/en/publications/c57d2d6c-2e2f-4b69-8cfe-a4c817f69cd3Test

الإتاحة: https://doi.org/10.1007/s13300-021-01156-1Test
https://discovery.dundee.ac.uk/en/publications/c57d2d6c-2e2f-4b69-8cfe-a4c817f69cd3Test
https://discovery.dundee.ac.uk/ws/files/68965782/McCrimmon2021_Article_Cost_EffectivenessOfIGlarLixiV.pdfTest
http://www.scopus.com/inward/record.url?scp=85118336012&partnerID=8YFLogxKTest

المؤلفون: Davies, Melanie J., Rosenstock, Julio, Ali, Amar, Russell‐Jones, David, Souhami, Elisabeth, Palmer, Karen, Ji, Chen, Niemoeller, Elisabeth, Skolnik, Neil

المساهمون: Sanofi

المصدر: Diabetes, Obesity and Metabolism ; volume 24, issue 1, page 34-41 ; ISSN 1462-8902 1463-1326

الإتاحة: https://doi.org/10.1111/dom.14543Test

المؤلفون: Guja, Cristian, Giorgino, Francesco, Blonde, Lawrence, Ali, Amar, Prázný, Martin, Meier, Juris J., Souhami, Elisabeth, Lubwama, Robert, Ji, Chen, Rosenstock, Julio

المساهمون: Sanofi

المصدر: Diabetes Therapy ; volume 13, issue 1, page 205-215 ; ISSN 1869-6953 1869-6961

مصطلحات موضوعية: Endocrinology, Diabetes and Metabolism, Internal Medicine

الإتاحة: https://doi.org/10.1007/s13300-021-01180-1Test

المؤلفون: Giorgino, Francesco, Rosenstock, Julio, Ritzel, Robert, Deyneli, Oğuzhan, Alvarez, Agustina, Souhami, Elisabeth, Melas-Melt, Lydie, McCrimmon, Rory J.

المصدر: Diabetologie und Stoffwechsel ; Vielfalt & Individualität - Diabetes neu denken www.diabeteskongress.de ; ISSN 1861-9010

الإتاحة: https://doi.org/10.1055/s-0043-1767989Test

المؤلفون: Handelsman, Yehuda, Chovanes, Christina, Dex, Terry, Giorgino, Francesco, Skolnik, Neil, Souhami, Elisabeth, Stager, William, Niemoeller, Elisabeth, Frias, Juan Pablo

المساهمون: Handelsman, Yehuda, Chovanes, Christina, Dex, Terry, Giorgino, Francesco, Skolnik, Neil, Souhami, Elisabeth, Stager, William, Niemoeller, Elisabeth, Frias, Juan Pablo

مصطلحات موضوعية: Elderly, Fixed-ratio combination, iGlarLixi, Insulin glargine, Lixisenatide, Type 2 diabete, Internal Medicine, Endocrinology, Diabetes and Metabolism

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30600136; info:eu-repo/semantics/altIdentifier/wos/WOS:000459522300011; volume:33; issue:3; firstpage:236; lastpage:242; numberofpages:7; journal:JOURNAL OF DIABETES AND ITS COMPLICATIONS; http://hdl.handle.net/11586/226016Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85059136356; www.elsevier.com/locate/jdiacomp

الإتاحة: https://doi.org/10.1016/j.jdiacomp.2018.11.009Test
http://hdl.handle.net/11586/226016Test